Showing 2,581 - 2,600 results of 18,470 for search 'significantly ((((((lower decrease) OR (a decrease))) OR (linear decrease))) OR (teer decrease))', query time: 0.66s Refine Results
  1. 2581
  2. 2582
  3. 2583
  4. 2584

    Amplitude for A/L = 0.29. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
  5. 2585

    Amplitude for A/L = 0.338. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
  6. 2586

    Amplitude for A/L = 0.02. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
  7. 2587

    Amplitude for A/L = 0.03. by Muhammad Hammad Bucha (21736111)

    Published 2025
    “…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
  8. 2588

    Cohort characteristics. by Vincent Pey (21433304)

    Published 2025
    “…</p><p>Results</p><p>Upon initiation of CPB we observed a significant decrease in arterial whole blood redox potential (101.90 mV + /- 11.52 vs. 41.80 mV + /- 10,26; p < 0.0001). …”
  9. 2589

    Genes show significant expression change in meta-analysis and their connection with Sjogren’s syndrome and thyroid cancer. by Fanyong Kong (20700261)

    Published 2025
    “…A gene in red indicates significantly increased expression in the meta-analysis, whereas a gene in blue indicates significantly decreased expression in the meta-analysis.…”
  10. 2590
  11. 2591
  12. 2592

    Table 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.doc... by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  13. 2593

    Image 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  14. 2594

    Image 2_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  15. 2595

    Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis by Lin Y.-T. (17065287)

    Published 2025
    “…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …”
  16. 2596
  17. 2597

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
  18. 2598
  19. 2599
  20. 2600

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…<p>In the recurrence group, the respective treatment counts for anti-VEGF, STTA, MA-PC, PPV, and total treatments (mean ± standard deviation) in the year before surgery were 3.0 ± 1.4, 0.1 ± 0.3, 0.8 ± 1.0, 0.1 ± 0.3, and 4.0 ± 2.1, respectively. These significantly decreased to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0.0, and 3.1 ± 2.8 in the first year; 2.1 ± 2.8, 0.4 ± 1.0, 0, 0.1 ± 0.3, and 2.6 ± 2.8 in the second year; and 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 in the third year (Kruskal–Wallis test, p < 0.001; Dunn’s test, *P < 0.05, **P < 0.01). …”